Check-Cap Ltd. (CHEK) Financials

CHEK Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 29.0 million 1.6 million
June 30, 2023 33.7 million 3.5 million
March 31, 2023 41.3 million 4.3 million
Dec. 31, 2022 45.4 million 4.1 million

CHEK Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -3.6 million -205000
June 30, 2023 -5.2 million 42000
March 31, 2023 -4.7 million 156000
Dec. 31, 2022 -4.2 million 100000

CHEK Net Income

No data available :(

CHEK Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 28.1 million - 30000
June 30, 2023 32.1 million - 83000
March 31, 2023 37.0 million - 983000
Dec. 31, 2022 41.7 million - 964000

CHEK Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 5.8 million
June 30, 2023 5.8 million
March 31, 2023 5.8 million
Dec. 31, 2022 5.8 million

CHEK Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 1282 30000 2.8 million -
June 30, 2023 18000 4.5 million 1.6 million -
March 31, 2023 65000 3.7 million 1.2 million -
Dec. 31, 2022 91000 3.0 million 1.3 million -

CHEK Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - -
June 30, 2023 - 95000
March 31, 2023 - 95000
Dec. 31, 2022 - -

CHEK

Price: $1.61

52 week price:
0.56
3.13

Earnings Per Share: -4.30 USD

P/E Ratio: -0.37

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Country: Israel

Volume: 211200

Ebitda: -7.9 million

Market Capitalization: 9.4 million

Links: